Showing 1,741 - 1,760 results of 9,864 for search '"drug"', query time: 0.11s Refine Results
  1. 1741
  2. 1742
  3. 1743
  4. 1744
  5. 1745
  6. 1746
  7. 1747
  8. 1748
  9. 1749
  10. 1750
  11. 1751
  12. 1752

    Detection of I491F and V170F rpoB mutations associated with misdiagnosis of rifampicin resistance among patients with drug-susceptible tuberculosis treatment failure, Myanmar, 2022 by Phyu Win Ei, Mi Mi Htwe, Myat Htut Nyunt, Aye Su Mon, Zaw Myint, Wint Wint Nyunt, Su Mon Win, Sandar Aung, Wai Myat Thwe, Wah Wah Aung

    Published 2025-03-01
    “…Methods: Sputum specimens from first-line TB treatment failed patients attending Tuberculosis Centers in Yangon Region during 2022 were cultured in solid media. Phenotypic drug susceptibility testing was conducted using Mycobacterial Growth Indicator Tube method. …”
    Get full text
    Article
  13. 1753
  14. 1754

    Differentiations in Illness Duration, Thyroid-Stimulating Hormone, Glucose and P300 Latency Between Drug-Naïve Unipolar and Bipolar Depression: A Comparative Cross-Sectional Study by Li C, Yang L, Zhang Q, Zhang Y, Li R, Jia F, Wang L, Ma X, Yao K, Tian H, Liu Z, Zhuo C

    Published 2025-01-01
    “…Chao Li,1,2 Lei Yang,1,2 Qiuyu Zhang,1,2 Ying Zhang,1,2 Ranli Li,1,2 Feng Jia,1,2 Lina Wang,1,2 Xiaoyan Ma,1,2 Kaifang Yao,1,2 Hongjun Tian,3,* Zengxun Liu,4,* Chuanjun Zhuo1,2,* 1Computational Biology and Animal Imaging Center (CBAC), Tianjin Anding Hospital, Nankai University Affiliated Tianjin Anding Hospital, Tianjin Medical University Affiliated Tianjin Anding Hospital, Tianjin Medical University Affiliated Tianjin Mental Health Center, Tianjin, 300222, People’s Republic of China; 2Laboratory of Psychiatric-Neuroimaging-Genetic and Co-morbidity (PNGC_Lab), Tianjin Anding Hospital, Tianjin Mental Health Center of Tianjin Medical University, Tianjin, 300222, People’s Republic of China; 3Department of Psychiatry, Tianjin Fourth Center Hospital, Nankai University Affiliated Tianjin Fourth Center Hospital, Tianjin, 300140, People’s Republic of China; 4Department of Psychiatry, Shandong Mental Health Center, Jinan, 250014, People’s Republic of China*These authors contributed equally to this workCorrespondence: Chuanjun Zhuo, Tianjin Anding Hospital, Nankai University Affiliated Tianjin Anding Hospital, Tianjin Medical University Affiliated Tianjin Anding Hospital, Tianjin Medical University Affiliated Tianjin Mental Health Center, Tianjin, 300222, People’s Republic of China, Tel/Fax +86-22-24394542, Email chuanjunzhuotjmh@163.comBackground: Distinguishing bipolar depression (BD) from unipolar depression (UD) remains a major clinical challenge, especially in drug-naïve patients. The present study aimed to investigate whether demographic, clinical, and biochemical parameters can help differentiate drug-naïve BD from UD.Methods: Drug-naïve patients with UD and BD were recruited from Shandong Mental Health Center. …”
    Get full text
    Article
  15. 1755

    Polyhydroxyalkanoates Biopolymer Production by Moderately Halophilic Paracoccus onubensis Strain E3: Extraction, Characterization and Synergistic Activity with Sorafenib Drug against Hepatocellular Carcinoma through Molecular Docking Approach by Hend A. Hamedo, Ahmed E.M. Shokr, Omnia T. Abd-Elsalam, Naglaa Elshafey

    Published 2025-01-01
    “…Our findings indicate that Paracoccus onubensis strain E3 is a promising candidate for producing PHAs, which could be used as a drug delivery system for HCC treatment with sorafenib drug. …”
    Get full text
    Article
  16. 1756
  17. 1757
  18. 1758

    Τhiazolidine-4-One Derivatives with Variable Modes of Inhibitory Action Against DPP4, a Drug Target with Multiple Activities and Established Role in Diabetes Mellitus Type II by Dionysia Amanatidou, Phaedra Eleftheriou, Anthi Petrou, Athina Geronikaki, Theodoros Lialiaris

    Published 2025-01-01
    “…While a number of drugs with competitive inhibitory action and covalent binding capacity are available, undesired side effects exist partly attributed to drug kinetics, and research for finding novel, potent, and safer compounds continues. …”
    Get full text
    Article
  19. 1759

    Prediction of long-term drug-free outcomes in ACPA-positive and ACPA-negative rheumatoid arthritis by combined clinical and ultrasound assessment of residual disease: a 5-year prospective study by Carlomaurizio Montecucco, Garifallia Sakellariou, Claudia Alpini, Catherine Klersy, Serena Bugatti, Ludovico De Stefano, Emanuele Bozzalla Cassione, Antonio Manzo, Blerina Xoxi, Terenzj Luvaro, Ylenia Sammali

    Published 2025-01-01
    “…Objective To delineate, within the framework of current clinical practice and criteria, the sustainability of first-line immuno-suppressive treatment discontinuation in rheumatoid arthritis (RA) and the impact of residual disease in remission on long-term drug-free (DF) outcomes.Methods RA patients, referring to the Pavia early arthritis clinic (EAC) between 2009 and 2021 and achieving remission after Disease Activity Score-driven methotrexate (MTX) monotherapy, were recruited. …”
    Get full text
    Article
  20. 1760